Title for MeetingAbstracts

Alphabetical listing of titles

• Process improvement in Medicaments and Health Technology General Direction. A Mexican strategic line in Health Technology Evaluation and Management.
• Process indicator information system: a tool for monitoring and evaluating HIV/AIDS prevention programs.
• Process of care outcomes to measure changing behaviour in diabetes management: preliminary results of a cluster-randomized controlled trial (C-RCT) among general practitioners (GPs) of Lazio region, Italy.
• Process of CSOs capacity building.
• Process of sistematization for the articulation between Government and Non-Governmental Organizations in the State of Sao Paulo.
• Process oriented training for sustainable HIV/AIDS prevention.
• Process oriented training of health professionals attending people HIV+ or with AIDS.
• Processes and Outcomes in the Transition of Care for Youth with Chronic Childhood Illness.
• Processes and outcomes of care in rural ICUs: preliminary findings.
• Processes Contributing to Failure to Rescue in Acute Care Hospitals.
• Processes of orphanhood:understanding the lifeworlds of HIV/AIDS impacted children.
• Processing and assembly of HIV-1 core antigens expressed by recombinant vaccinia virus.
• Processing mechanisms for the HIV-1 envelope protein for recognition by CD8+ cytolytic T lymphocytes.
• Processing of gag and pol polypeptides as in vitro model for protease inhibitor studies in eukaryotic target cells.
• Processing of HIV unintegrated DNA in infected cells.
• Processing of modified DNA substrates by HIV-1 integrase.
• Processing of the gag polyprotein by human immunodeficiency virus protease occurs in a sequential manner.
• Processing of the HIV gp160 by the Kex2p endoprotease from the yeast Saccharomyces cerevisiae.
• Processing of the HIV-1 gag-pol precursor protein.
• Processivity analysis of HIV-1 RT variants.
• Procreation and HIV-infection: legal and ethical issues.
• Procurement and availability of ARVs and lab reagents for HIV/AIDS treatment and testing in Uganda.
• Procurement and distribution of antiretroviral therapy in rural Haiti.
• Procurement distribution and availability of supplies for HIV/AIDS care in Uganda.
• Procurement Price Regulation and Generic Competition.
• Procysteine (L-2-oxothiazolidine-4-carboxylic acid) reduces the toxicity of AZT (zidovudine) and enhances the antiviral activity of AZT in cultured peripheral blood mononuclear cells (PBMC).
• Procysteine inhibits TNF-alpha induced HIV production in U1 cells.
• Prodrug Strategies to Deliver Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) GW8248 and GW8635.
• Prodrugs of Anti-MRSA Cephalosporin RWJ-333441 (MC-04,546) with Improved Aqueous Solubility.
• Producing a video package: "ALL TALK". Relationship skills, HIV/AIDS and young people.